IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 3 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,626,000 | -11.2% | 8,797,000 | 0.0% | 0.76% | -50.4% |
| Q2 2018 | $41,232,000 | -20.6% | 8,797,000 | -50.0% | 1.54% | +10.7% |
| Q1 2018 | $51,944,000 | +81.6% | 17,594,000 | +100.0% | 1.39% | +86.3% |
| Q4 2017 | $28,605,000 | +14.8% | 8,797,000 | 0.0% | 0.74% | +42.4% |
| Q3 2017 | $24,910,000 | +94.1% | 8,797,000 | +25.7% | 0.52% | +55.2% |
| Q2 2017 | $12,833,000 | – | 7,000,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 4,614,000 | $19,166,000 | 0.22% |
| Calamos Advisors LLC | 2,500,000 | $10,398,000 | 0.05% |
| EVOKE WEALTH, LLC | 569 | $12,040,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |